p.R69I | TCGA-2W-A8YY | CESC | TCGA | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.R69I | TCGA-B5-A0JY | UCEC | TCGA | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.R69I | DO223732 | CESC | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.R69I | DO43041 | UCEC | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.P58T | TCGA-DZ-6131 | KIRP | TCGA | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1944 |
p.P58T | DO20911 | KIRP | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1944 |
p.R71C | TCGA-ZF-AA5N | BLCA | TCGA | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2222 |
p.R71C | DO219102 | BLCA | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2222 |
p.G134V | DO50398 | ESAD | ICGC | APSTT | DEG_SPOP_SBC_1 | 140:144 | Mutation rewiring degron network | 0.1667 |
p.A68E | DO228976 | LICA | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.D150E | DO229037 | LICA | ICGC | APSTT | DEG_SPOP_SBC_1 | 140:144 | Mutation rewiring degron network | 0.1667 |
p.A68V | DO227848 | PBCA | ICGC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | SIDM00845 | Burkitt's Lymphoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | SIDM00461 | Acute Myeloid Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | SIDM00946 | T-Lymphoblastic Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | SIDM01519 | Head and Neck Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | OCI-AML5 | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.A68V | Daudi | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation blocking ubiquitination signal | 0.75 |
p.D140A | DO219881 | SKCA | ICGC | APSTT | DEG_SPOP_SBC_1 | 140:144 | Mutation altering degron motif | 0.7793 |
p.P70A | SIDM00845 | Burkitt's Lymphoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.P70A | SIDM00461 | Acute Myeloid Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.P70A | SIDM00946 | T-Lymphoblastic Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.P70A | SIDM01519 | Head and Neck Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.P70A | Daudi | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.P70A | OCI-AML5 | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.25 |
p.M147L | SIDM00017 | Squamous Cell Lung Carcinoma | GDSC | APSTT | DEG_SPOP_SBC_1 | 140:144 | Mutation rewiring degron network | 0.25 |
p.D69A | ACH-000786 | Lymphoma | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.D69A | ACH-000992 | Head and Neck Cancer | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.D69A | Daudi | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.D69A | OCI-AML5 | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.2778 |
p.P55A | ACH-000786 | Lymphoma | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1111 |
p.P55A | ACH-000992 | Head and Neck Cancer | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1111 |
p.P55A | Daudi | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1111 |
p.P55A | OCI-AML5 | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.1111 |
p.A53V | ACH-000786 | Lymphoma | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.0556 |
p.A53V | ACH-000992 | Head and Neck Cancer | CCLE | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.0556 |
p.A53V | OCI-AML5 | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.0556 |
p.A53V | Daudi | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 63:67 | Mutation rewiring degron network | 0.0556 |
p.M132L | ACH-000912 | Lung Cancer | CCLE | APSTT | DEG_SPOP_SBC_1 | 140:144 | Mutation rewiring degron network | 0.1111 |